Cognitive impairment is a significant cause of disability for many people with Multiple Sclerosis. To alleviate or slow the progression of cognitive impairment, non-drug interventions are studied – but which are the most promising?     On this episode, Dr. Mark Bayley interviews Dr. Katherine Knox and Dr. Sarah Morrow about the key findings from MSBEST’s systematic review on non-drug interventions evaluating cognitive impairment in MS. They discuss which interventions may help, clinical implications and future directions. You may find the complete MSBEST systematic reviews on interventions for cognition on our website: msbest.ca.      MSBEST systematic reviews cover topics that are important to the independence and quality of life of people living with MS. Reviews and podcasts target health care providers and researchers to advance evidence-based MS care.